Eli Lilly plans $18B manufacturing site and $19.3M funding in Lebanon
What happened
Eli Lilly and Company is constructing a massive pharmaceutical manufacturing site in Lebanon, committing $18 billion to the LEAP Research and Innovation District. The company is also proposing a restricted transfer agreement to provide up to $19.3 million over 10 years to the city of Lebanon. This funding is intended to expand the Lebanon Fire Department’s hazardous materials response capabilities, including hiring 12 new firefighters and purchasing new equipment.
Why it matters
The corporate investment represents a significant influx of capital into Lebanon. The funding agreement requires the city to meet specific benchmarks in subsequent years, such as maintaining staffing levels and ensuring equipment maintenance, to continue receiving the funds.
Who's involved
- Eli Lilly and CompanyProposing the $18 billion manufacturing investment and $19.3 million funding agreement to the city.
- LebanonThe city receiving the major corporate investment and the funding agreement for its fire department.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- LebanonSpeculative
Lebanon might see increased local economic stimulus and costs associated with the expansion of its fire department.
- Eli Lilly and CompanySpeculative
Eli Lilly and Company might see increased revenue and operational capacity from the new pharmaceutical manufacturing site.
- IndianaSpeculative
Indiana might see increased tax revenue and economic stimulus from the corporate investment.
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Lebanon
city in Marion County, Kentucky, United States
Related events
- Eli Lilly and Company issued a press release from Indianapolis and presented data at a conference in Las Vegas.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Eli Lilly and Company was involved in a business event in Indianapolis where Mike Doustdar acknowledged the superiority of Lilly's pill.
- Soutrik Banerjee is currently employed as a consultant at Eli Lilly and Company.
- Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.